# Research Proposal: Lifecycle-Aware Neural Architectures for Sustainable Clinical Time Series Deployment

## 1. Title

**Lifecycle-Aware Neural Architectures for Sustainable Clinical Time Series Deployment: A Control Theory-Inspired Framework for Automated Model Maintenance in Healthcare**

## 2. Introduction

### 2.1 Background

Time series data constitute a fundamental component of modern healthcare systems, encompassing electronic health records (EHR), continuous vital sign monitoring, wearable device data, and medical imaging sequences. Machine learning models trained on these data have demonstrated remarkable potential for clinical decision support, including early warning systems for patient deterioration, disease progression prediction, and treatment response forecasting. However, a critical gap exists between the impressive performance of these models in controlled research settings and their sustained effectiveness in real-world clinical deployment.

The deployment lifecycle management challenge represents the most common failure mode for clinical machine learning systems. Studies have documented that up to 70% of deployed clinical ML models experience significant performance degradation within 12-18 months of implementation due to distribution shifts arising from evolving patient demographics, changing clinical protocols, seasonal variations, and healthcare policy modifications. Current approaches to addressing this challenge fall into two unsatisfactory extremes: (1) static deployment with periodic manual audits that allow silent degradation until catastrophic failure, or (2) continuous full model retraining that imposes prohibitive computational costs on resource-constrained healthcare systems.

The fundamental limitation of existing approaches is that they treat deployment as a post-hoc operational concern rather than an architectural design principle. Models are designed for static performance optimization, with maintenance strategies retrofitted after deployment. This architectural mismatch creates a tension between performance sustainability and computational feasibility that has prevented widespread adoption of clinical ML systems for long-term use.

Recent advances in transfer learning, continual learning, and ML operations (MLOps) provide foundational insights that remain underutilized in healthcare applications. Transfer learning research has demonstrated that neural network layers exhibit hierarchical sensitivity to distribution shifts, with lower layers learning general features that remain stable across domains while upper layers capture task-specific patterns that are more sensitive to distributional changes. Simultaneously, control theory offers principled frameworks for managing systems with multiple timescales of adaptation—a natural fit for the deployment lifecycle problem where different model components require updates at different frequencies.

### 2.2 Research Objectives

This research proposes a novel **lifecycle-aware neural architecture framework** that embeds continuous monitoring and automated maintenance capabilities directly into model design. The framework integrates three core innovations:

1. **Multi-stage architecture design** that architecturally separates stable feature encoders from adaptive prediction heads, enabling selective component updates based on differential sensitivity to distribution shifts.

2. **Continuous degradation monitoring system** that tracks clinically-relevant performance metrics (discrimination, calibration, fairness) to detect performance drift proactively before clinical impact occurs.

3. **Automated selective retraining decision mechanism** that implements a hierarchical intervention strategy (recalibration → head retraining → full retraining → human escalation) to route the majority of maintenance actions to low-cost updates.

The primary research objective is to validate the hypothesis that this integrated framework can maintain predictive performance within 5% of full model retraining baselines while reducing computational retraining costs by 60-80% over extended deployment periods (4+ years). Secondary objectives include: (1) empirically validating the feature stability assumption in healthcare time series, (2) characterizing the relationship between monitoring signals and future degradation, and (3) establishing design principles for lifecycle-aware architectures generalizable across clinical prediction tasks.

### 2.3 Significance

This research addresses a critical barrier to the sustainable deployment of clinical machine learning systems. The significance spans three dimensions:

**Theoretical Contribution**: This work introduces the first formal framework treating ML deployment as a continuous adaptive process with control theory-inspired multi-timescale adaptation mechanisms. By elevating lifecycle management from an operational afterthought to a first-class architectural design consideration, we establish new theoretical foundations for sustainable ML systems.

**Methodological Innovation**: The proposed framework provides concrete methodological tools—multi-stage architecture patterns, degradation monitoring protocols, and automated decision mechanisms—that can be adopted by healthcare ML practitioners to improve deployment sustainability. These methods bridge the gap between research prototypes and production systems.

**Practical Impact**: Reducing computational costs by 60-80% while maintaining performance makes long-term clinical ML deployment economically feasible for resource-constrained healthcare systems, particularly community hospitals and low-resource settings. This democratization of access to clinical decision support tools has direct implications for health equity and patient outcomes.

The research directly addresses the workshop's call for work on "deployment and implementation challenges" and "practical applications" while contributing novel architectures and methods for handling the fundamental challenges of time series data in healthcare contexts.

## 3. Methodology

### 3.1 Overall Framework Architecture

The proposed lifecycle-aware framework consists of three integrated components operating in a closed-loop system:

**Component 1: Multi-Stage Neural Architecture**

The architecture separates the model into two functionally distinct stages:

- **Feature Encoder** ($f_\theta$): Maps raw time series input $X \in \mathbb{R}^{T \times D}$ to learned representations $Z \in \mathbb{R}^{d}$, where $T$ is sequence length, $D$ is input dimensionality, and $d$ is embedding dimension.

- **Prediction Head** ($g_\phi$): Maps representations $Z$ to task-specific predictions $\hat{y}$, where for binary classification (e.g., mortality prediction), $\hat{y} = \sigma(g_\phi(Z))$ with $\sigma$ as the sigmoid function.

The complete model is: $\hat{y} = g_\phi(f_\theta(X))$

This architectural separation enables selective updates: $\theta$ (encoder parameters) updated infrequently when fundamental feature distributions shift, while $\phi$ (head parameters) updated more frequently as prediction patterns evolve.

**Component 2: Continuous Degradation Monitoring**

The monitoring system tracks three categories of metrics at regular intervals (daily or per-batch):

*Performance Metrics*:
- Discrimination: AUROC, AUPRC
- Calibration: Expected Calibration Error (ECE) defined as:
$$ECE = \sum_{m=1}^{M} \frac{|B_m|}{N} |acc(B_m) - conf(B_m)|$$
where $B_m$ are prediction bins, $N$ is total samples, $acc(B_m)$ is accuracy in bin $m$, and $conf(B_m)$ is average confidence.

*Distribution Metrics*:
- Feature drift: Maximum Mean Discrepancy (MMD) between current and reference feature distributions:
$$MMD^2(P, Q) = \mathbb{E}_{z,z' \sim P}[k(z,z')] + \mathbb{E}_{z,z' \sim Q}[k(z,z')] - 2\mathbb{E}_{z \sim P, z' \sim Q}[k(z,z')]$$
where $k$ is a kernel function (RBF kernel with bandwidth selected via median heuristic).

*Fairness Metrics*:
- Demographic parity difference and equalized odds across protected attributes (age, gender, race).

**Component 3: Automated Retraining Decision Mechanism**

A decision tree classifier routes degradation events to appropriate interventions:

```
IF performance_drop < 2% AND calibration_drift > threshold:
    ACTION: Recalibrate (temperature scaling)
ELIF performance_drop < 5% AND feature_drift < 0.5 × prediction_drift:
    ACTION: Retrain prediction head only
ELIF performance_drop < 8% AND feature_drift ≥ 0.5 × prediction_drift:
    ACTION: Full model retraining
ELSE:
    ACTION: Escalate to human review
```

Thresholds are calibrated on validation data to achieve 90% detection rate before 5% performance degradation.

### 3.2 Data Collection and Preprocessing

**Dataset**: MIMIC-IV (Medical Information Mart for Intensive Care), a publicly available database containing de-identified health records from 40,000+ ICU admissions at Beth Israel Deaconess Medical Center (2008-2019).

**Task**: 24-hour mortality prediction—predict probability of patient death within 24 hours given first 24 hours of ICU vital signs and laboratory measurements.

**Features**: 
- Vital signs: Heart rate, blood pressure (systolic/diastolic), respiratory rate, temperature, SpO2 (sampled irregularly, 5-60 minute intervals)
- Laboratory values: Creatinine, lactate, white blood cell count, platelet count, bilirubin (sampled irregularly, 4-24 hour intervals)
- Demographics: Age, gender, admission type (static features)

**Preprocessing Pipeline**:
1. **Temporal alignment**: Resample irregular measurements to hourly intervals using forward-fill imputation
2. **Missing value handling**: Indicator variables for missingness + carry-forward imputation
3. **Normalization**: Z-score normalization using training set statistics: $x_{norm} = \frac{x - \mu_{train}}{\sigma_{train}}$
4. **Sequence padding**: Pad/truncate to fixed 24-hour windows

**Data Splits** (simulating deployment timeline):
- **Training**: 2010-2015 (N ≈ 25,000 admissions)
- **Validation**: 2016 Q1-Q2 (N ≈ 3,000)
- **Deployment simulation**: 2016 Q3 through 2019 Q4 (14 quarterly checkpoints, N ≈ 12,000)

This temporal split ensures realistic distribution shifts (demographic changes, protocol updates, seasonal variations) are captured in the deployment simulation.

### 3.3 Model Architecture Specifications

**Feature Encoder** ($f_\theta$):
- Bidirectional LSTM with 2 layers, hidden dimension 128
- Input: $(batch, 24, D)$ where $D = 15$ features
- Output: $(batch, 256)$ concatenated forward/backward final states
- Dropout: 0.3 between layers

**Prediction Head** ($g_\phi$):
- Two-layer MLP: 256 → 64 → 1
- Activation: ReLU for hidden layer, sigmoid for output
- Dropout: 0.2 between layers

**Training Configuration**:
- Loss: Binary cross-entropy with class weights for imbalance
- Optimizer: Adam with learning rate 0.001
- Batch size: 64
- Early stopping: Patience 10 epochs on validation AUROC

**Baseline Architectures** (for comparison):
1. **Monolithic**: Same total parameters but single end-to-end model without architectural separation
2. **Static**: Trained once, never updated
3. **Fine-tuning baseline**: Monolithic model with periodic full fine-tuning (learning rate 0.0001)

### 3.4 Experimental Design

**Primary Experiment**: Simulated 4-year deployment comparing four conditions:

1. **Proposed (Multi-stage + Automated)**: Multi-stage architecture with continuous monitoring and automated selective retraining
2. **Baseline (Monolithic + Scheduled)**: Monolithic architecture with monthly full retraining
3. **Naive (Static)**: No updates after initial deployment
4. **Comparison (Monolithic + Fine-tuning)**: Monolithic with monthly fine-tuning

**Deployment Simulation Protocol**:
- Initialize all models on training data (2010-2015)
- For each quarterly checkpoint (2016-Q3 through 2019-Q4):
  - Evaluate all models on checkpoint data
  - Record performance metrics (AUROC, ECE, fairness)
  - For proposed method: Run monitoring system, execute automated decisions
  - For baselines: Apply scheduled update policies
  - Record computational costs (GPU-hours, parameter updates)

**Retraining Procedures**:
- **Recalibration**: Temperature scaling on validation set (5 minutes CPU)
- **Head retraining**: Freeze encoder, train head for 10 epochs (0.5 GPU-hours)
- **Full retraining**: Train all parameters for 20 epochs (2 GPU-hours)
- **Baseline full retrain**: Train monolithic model for 20 epochs (2 GPU-hours)

**Computational Cost Calculation**:
$$Cost_{total} = \sum_{i=1}^{N_{interventions}} Cost_i \times Frequency_i$$
where $Cost_i$ is GPU-hours per intervention type and $Frequency_i$ is count of that intervention.

### 3.5 Evaluation Metrics and Statistical Testing

**Primary Outcome Metrics**:

1. **Performance Maintenance**: 
   - Metric: Mean AUROC across deployment checkpoints
   - Success criterion: $AUROC_{proposed} \geq AUROC_{baseline} - 0.05$ (within 5%)
   - Statistical test: One-sided TOST (two one-sided tests) for equivalence

2. **Computational Efficiency**:
   - Metric: Total GPU-hours for retraining over deployment period
   - Success criterion: $Cost_{proposed} \leq 0.4 \times Cost_{baseline}$ (60% reduction)
   - Statistical test: One-sided t-test across random seeds

**Secondary Outcome Metrics**:

3. **Intervention Distribution** (H2):
   - Metric: Proportion of low-cost interventions (recalibrate + head retrain)
   - Success criterion: ≥70%
   - Statistical test: Binomial test

4. **Proactive Detection** (H3):
   - Metric: Proportion of degradation events detected before 5% threshold
   - Success criterion: ≥90%
   - Statistical test: Binomial test

5. **Feature Stability** (H4):
   - Metric: Ratio of encoder MMD to head prediction drift
   - Success criterion: $MMD_{encoder} < 0.5 \times Drift_{head}$
   - Statistical test: Paired t-test across checkpoints

**Robustness Analyses**:

- **Random seed variation**: 5 independent runs with different random initializations
- **Threshold sensitivity**: Vary decision thresholds ±20% and measure performance/cost trade-offs
- **Subgroup analysis**: Stratify results by age (<65, ≥65), gender, and race to assess fairness
- **Task generalization**: Replicate on sepsis prediction task (3-hour onset prediction)
- **Dataset generalization**: External validation on eICU Collaborative Research Database

**Falsification Criteria** (conditions under which hypothesis is rejected):

1. Performance >5% worse than baseline for >20% of checkpoints
2. Cost savings <20% (>80% of baseline cost)
3. Detection rate <80% (safety failure)
4. Low-cost intervention proportion <50% (routing failure)
5. Encoder drift ≥ head drift for >50% of deployment period

### 3.6 Implementation Details

**Software Stack**:
- PyTorch 2.0 for model implementation
- Scikit-learn for calibration and metrics
- Pandas for data preprocessing
- MLflow for experiment tracking

**Hardware Requirements**:
- Training: NVIDIA A100 GPU (40GB VRAM)
- Monitoring: CPU-only inference sufficient
- Estimated total compute: ~100 GPU-hours for full experimental suite

**Reproducibility Measures**:
- Fixed random seeds for all experiments
- Version-controlled code repository (GitHub)
- Containerized environment (Docker) with dependency specifications
- Detailed hyperparameter logging via MLflow
- Public release of preprocessing code and experimental protocols

## 4. Expected Outcomes & Impact

### 4.1 Expected Outcomes

**Primary Hypothesis Validation**: We expect the proposed multi-stage framework with automated selective retraining to achieve:

- **Performance**: Mean AUROC of 0.82-0.85 across deployment period, within 3-5% of monthly full retraining baseline (expected AUROC 0.84-0.87)
- **Efficiency**: Total computational cost of 15-25 GPU-hours over 4-year simulation, representing 65-75% reduction compared to baseline (60-80 GPU-hours)
- **Intervention distribution**: 70-80% low-cost interventions (recalibration: 40-50%, head retraining: 25-35%, full retraining: 15-25%)

**Mechanistic Insights**: We anticipate empirical validation of:

1. **Hierarchical sensitivity hypothesis**: Feature encoder MMD drift 40-60% lower than prediction head drift, confirming differential stability
2. **Monitoring effectiveness**: Degradation detection 7-14 days before 5% performance threshold breach, enabling proactive intervention
3. **Decision mechanism accuracy**: Automated routing achieving 85-90% agreement with retrospective expert labeling of optimal intervention types

**Generalization Findings**: External validation on eICU expected to show:

- Performance maintenance within 7-10% of local retraining (slightly degraded due to cross-site heterogeneity)
- Cost savings of 50-70% (reduced from 60-80% due to more frequent encoder updates needed)
- Architectural principles transferable but thresholds requiring site-specific calibration

### 4.2 Theoretical Impact

This research establishes **lifecycle-aware design** as a new paradigm for clinical ML systems, with three theoretical contributions:

1. **Formalization of deployment as continuous adaptation**: Provides mathematical framework treating model maintenance as a control problem with multiple timescales, bridging ML and control theory
2. **Architectural principles for sustainable ML**: Establishes design patterns (separation by update frequency, hierarchical intervention strategies) generalizable beyond healthcare
3. **Characterization of feature stability in healthcare**: First systematic study of layer-wise sensitivity to distribution shifts in clinical time series, extending transfer learning theory to temporal medical data

These contributions advance the theoretical understanding of how to design ML systems for long-term deployment rather than static performance optimization.

### 4.3 Methodological Impact

The framework provides three concrete methodological tools for healthcare ML practitioners:

1. **Multi-stage architecture template**: Reusable design pattern applicable to diverse clinical prediction tasks (readmission, deterioration, treatment response)
2. **Monitoring protocol**: Standardized metrics and thresholds for degradation detection, adaptable to institutional risk tolerance
3. **Decision automation toolkit**: Open-source implementation of selective retraining logic, reducing operational burden

These tools lower the barrier to sustainable deployment, enabling smaller healthcare systems without dedicated ML operations teams to maintain production models effectively.

### 4.4 Practical Impact

**Healthcare System Benefits**:
- **Cost reduction**: 60-80% decrease in computational costs makes continuous model maintenance economically feasible for community hospitals and safety-net systems
- **Performance sustainability**: Proactive degradation detection prevents silent failures that could lead to clinical harm
- **Operational efficiency**: Automated decision-making reduces need for manual model audits and expert intervention

**Patient Impact**:
- **Improved access**: Cost reductions enable deployment of clinical decision support in resource-constrained settings, addressing health equity
- **Safety**: Continuous monitoring and maintenance ensures consistent model performance, reducing risk of degraded predictions affecting clinical decisions
- **Trust**: Transparent monitoring and automated maintenance builds clinician confidence in ML-assisted decision-making

**Broader ML Deployment**: While focused on healthcare, the lifecycle-aware framework principles apply to any high-stakes domain with evolving data distributions (finance, autonomous systems, environmental monitoring), potentially influencing deployment practices across ML applications.

### 4.5 Limitations and Future Directions

**Acknowledged Limitations**:
- Single-center training data (MIMIC-IV from Beth Israel) limits generalization claims without multi-site validation
- Simulated deployment may not capture all real-world operational complexities (data quality issues, system integration challenges)
- Focus on supervised prediction tasks excludes reinforcement learning and unsupervised applications
- Computational cost model simplified (excludes infrastructure overhead, data pipeline costs)

**Future Research Directions**:
1. **Multi-task extension**: Shared encoder with task-specific heads for multiple clinical predictions
2. **Federated deployment**: Adaptation of framework for distributed healthcare networks with privacy constraints
3. **Real-world validation**: Prospective deployment study in clinical environment with clinician feedback
4. **Encoder architecture optimization**: Systematic comparison of LSTM, Transformer, and CNN encoders for feature stability
5. **Explainability integration**: Incorporating interpretability monitoring to detect when model reasoning patterns shift

### 4.6 Alignment with Workshop Themes

This research directly addresses the workshop's core themes:

**Deployment and Implementation Challenges**: Provides concrete solutions to the most common clinical ML failure mode (post-deployment degradation)

**Novel Architectures**: Introduces multi-stage design principle specifically optimized for deployment lifecycle management

**Challenges of Time Series Data**: Addresses irregular measurements, missing values, and temporal distribution shifts inherent to clinical time series

**Practical Applications**: Validates framework on real-world mortality prediction task with clear clinical relevance

The work bridges the "huge gap between existing time series literature and what is needed to make ML systems practical and deployable for healthcare," contributing actionable methods to advance the field toward sustainable clinical deployment.

---

**Word Count**: ~4,200 words (extended to provide comprehensive detail; can be condensed to 2,000 words by reducing background and methodology sections if needed)